vs
AST SpaceMobile, Inc.（ASTS）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是AST SpaceMobile, Inc.的1.1倍（$57.3M vs $54.3M），RHYTHM PHARMACEUTICALS, INC.净利率更高（-83.0% vs -136.2%，领先53.2%），AST SpaceMobile, Inc.同比增速更快（2758.2% vs 36.9%）
AST SpaceMobile是总部位于美国得克萨斯州米德兰的上市卫星设计与制造企业，目前正搭建SpaceMobile卫星星座，打造可直接对接未改装普通智能手机的天基蜂窝宽带网络，面向全球偏远及通信服务薄弱地区提供4G、5G宽带覆盖服务。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
ASTS vs RYTM — 直观对比
营收规模更大
RYTM
是对方的1.1倍
$54.3M
营收增速更快
ASTS
高出2721.3%
36.9%
净利率更高
RYTM
高出53.2%
-136.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $54.3M | $57.3M |
| 净利润 | $-74.0M | $-47.5M |
| 毛利率 | — | 91.6% |
| 营业利润率 | -175.0% | -82.2% |
| 净利率 | -136.2% | -83.0% |
| 营收同比 | 2758.2% | 36.9% |
| 净利润同比 | -106.3% | -9.6% |
| 每股收益（稀释后） | — | $-0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTSRYTM
| Q4 25 | $54.3M | $57.3M | ||
| Q3 25 | $14.7M | $51.3M | ||
| Q2 25 | — | $48.5M | ||
| Q1 25 | — | $32.7M | ||
| Q4 24 | — | $41.8M | ||
| Q3 24 | — | $33.3M | ||
| Q2 24 | — | $29.1M | ||
| Q1 24 | — | $26.0M |
净利润ASTSRYTM
| Q4 25 | $-74.0M | $-47.5M | ||
| Q3 25 | $-122.9M | $-52.9M | ||
| Q2 25 | — | $-46.6M | ||
| Q1 25 | — | $-49.5M | ||
| Q4 24 | — | $-43.3M | ||
| Q3 24 | — | $-43.6M | ||
| Q2 24 | — | $-32.3M | ||
| Q1 24 | — | $-141.4M |
毛利率ASTSRYTM
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
营业利润率ASTSRYTM
| Q4 25 | -175.0% | -82.2% | ||
| Q3 25 | -1109.0% | -102.6% | ||
| Q2 25 | — | -93.4% | ||
| Q1 25 | — | -143.7% | ||
| Q4 24 | — | -98.6% | ||
| Q3 24 | — | -132.0% | ||
| Q2 24 | — | -139.2% | ||
| Q1 24 | — | -538.7% |
净利率ASTSRYTM
| Q4 25 | -136.2% | -83.0% | ||
| Q3 25 | -833.7% | -103.1% | ||
| Q2 25 | — | -96.1% | ||
| Q1 25 | — | -151.4% | ||
| Q4 24 | — | -103.6% | ||
| Q3 24 | — | -131.2% | ||
| Q2 24 | — | -110.9% | ||
| Q1 24 | — | -544.4% |
每股收益（稀释后）ASTSRYTM
| Q4 25 | — | $-0.73 | ||
| Q3 25 | — | $-0.82 | ||
| Q2 25 | — | $-0.75 | ||
| Q1 25 | — | $-0.81 | ||
| Q4 24 | — | $-0.71 | ||
| Q3 24 | — | $-0.73 | ||
| Q2 24 | — | $-0.55 | ||
| Q1 24 | — | $-2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.3B | $388.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.4B | $139.1M |
| 总资产 | $5.0B | $480.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTSRYTM
| Q4 25 | $4.3B | $388.9M | ||
| Q3 25 | $2.4B | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | — | $319.1M | ||
| Q1 24 | — | $201.2M |
股东权益ASTSRYTM
| Q4 25 | $2.4B | $139.1M | ||
| Q3 25 | $1.6B | $148.8M | ||
| Q2 25 | — | $-11.9M | ||
| Q1 25 | — | $18.9M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | — | $11.2M | ||
| Q2 24 | — | $39.3M | ||
| Q1 24 | — | $61.6M |
总资产ASTSRYTM
| Q4 25 | $5.0B | $480.2M | ||
| Q3 25 | $2.6B | $506.9M | ||
| Q2 25 | — | $372.7M | ||
| Q1 25 | — | $386.7M | ||
| Q4 24 | — | $392.3M | ||
| Q3 24 | — | $363.6M | ||
| Q2 24 | — | $381.8M | ||
| Q1 24 | — | $258.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $65.0M | $-25.4M |
| 自由现金流经营现金流 - 资本支出 | $-330.7M | — |
| 自由现金流率自由现金流/营收 | -609.0% | — |
| 资本支出强度资本支出/营收 | 728.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-790.4M | — |
8季度趋势，按日历期对齐
经营现金流ASTSRYTM
| Q4 25 | $65.0M | $-25.4M | ||
| Q3 25 | $-64.5M | $-26.6M | ||
| Q2 25 | — | $-23.3M | ||
| Q1 25 | — | $-40.4M | ||
| Q4 24 | — | $-18.8M | ||
| Q3 24 | — | $-25.2M | ||
| Q2 24 | — | $-29.1M | ||
| Q1 24 | — | $-40.7M |
自由现金流ASTSRYTM
| Q4 25 | $-330.7M | — | ||
| Q3 25 | $-302.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ASTSRYTM
| Q4 25 | -609.0% | — | ||
| Q3 25 | -2055.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ASTSRYTM
| Q4 25 | 728.7% | — | ||
| Q3 25 | 1617.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTS
| Products | $44.4M | 82% |
| Other | $7.8M | 14% |
| Sat Co | $2.1M | 4% |
RYTM
暂无分部数据
